These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23389838)

  • 1. Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling.
    Caron V; Hu Y; Tajber L; Erxleben A; Corrigan OI; McArdle P; Healy AM
    AAPS PharmSciTech; 2013 Mar; 14(1):464-74. PubMed ID: 23389838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
    Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
    Shi X; Xu T; Huang W; Fan B; Sheng X
    AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
    Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
    Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
    Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
    AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colyophilized Sugar-Polymer Dispersions for Enhanced Processing and Storage Stability.
    Giannachi C; Allen E; Egan G; Vucen S; Crean A
    Mol Pharm; 2024 Jun; 21(6):3017-3026. PubMed ID: 38758116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
    Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
    Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
    Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
    Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility parameter-based screening methods for early-stage formulation development of itraconazole amorphous solid dispersions.
    Piccinni P; Tian Y; McNaughton A; Fraser J; Brown S; Jones DS; Li S; Andrews GP
    J Pharm Pharmacol; 2016 May; 68(5):705-20. PubMed ID: 26864155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA; Neau SH
    Drug Dev Ind Pharm; 2016 Mar; 42(3):446-455. PubMed ID: 26266965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
    Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
    Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R; Sieger P; Karmwar P
    Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat.
    Kini A; Patel SB
    Pharm Dev Technol; 2017 Feb; 22(1):45-57. PubMed ID: 26853838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
    Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
    Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
    Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.